{"groups":[{"description":"Patients receive gemcitabine hydrochloride IV over 30 minutes on day 1 and cisplatin IV on day 1 or divided over days 1 and 2. Treatment repeats every 14 days for 3 courses in the absence of disease progression or unacceptable toxicity. Beginning 3-8 weeks after chemotherapy, patients undergo radical cystectomy.\n\ngemcitabine hydrochloride: Given IV\n\ncisplatin: Given IV\n\ntherapeutic conventional surgery: Undergo radical cystectomy\n\nlaboratory biomarker analysis: Correlative studies","id":"FG000","title":"Treatment (Gemcitabine Hydrochloride, Cisplatin, Surgery)"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"32"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"31"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}